http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20121390-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_924e7c147fb3152f6e8677ea3d8454c9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-88
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71fba7f42869e8ffca8fb25dd532cf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428dd0dcc75983335a2009fa94f7eaa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d788e59b44a626a81c23b7e7af7b99fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c0ccf8432b2d488ea7866afc2f3baa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a10cb8eaa4731a91b0c7d9408ba0d28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d2081f30a5d73b40dcc41f7d811152f
publicationDate 2012-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20121390-A1
titleOfInvention DERIVATIVES OF 2- (1H-PIRAZOLO [3,4-d] PYRIMIDIN-1-ILMETIL) QUINAZOLIN-4 (3H) -ONA
abstract REFERS TO COMPOUNDS DERIVED FROM 2- (1H-PYRAZOLO [3,4-d] PYRIMIDIN-1-ILMETHYL) QUINAZOLIN-4 (3H) -ONE OF FORMULA (I) WHERE R1 IS H, ALKYL (C1-C15) IN WHERE ONE OR SEVERAL CARBONS CAN BE REPLACED BY A HETEROATOM SUCH AS O, N, AMONG OTHERS AND IS OPTIONALLY SUBSTITUTED WITH HALOGEN, ARYL, HETEROARIL, AMONG OTHERS; R3a IS HYDROXYL; R3b IS H, HYDROXYL, HALO, CN, AMONG OTHERS; R4 AND R5 ARE EACH H OR ALKYL (C1-C3); X IS ARYL (C6-C10) OR HETEROARYL (C5-C9) SUBSTITUTED WITH R2a AND R2b, WHERE R2a IS H, ALKYL (C1-C3), HALO, CN, AMONG OTHERS; R2b IS H, ALKYL (C1-C3), HALO, HALOALKYL (C1-C3). THE PREFERRED COMPOUNDS ARE: 2 - ((4-AMINO-3- (3-HYDROXYPHENYL) -1H-PIRAZOLO [3,4-d] PYRIMIDIN-1-IL) METHYL) -3- (2-CHLOROBENZYL) -5-ETHINYLQUINAZOLINE -4 (3H) -ONA; 6- (2 - ((4-AMINO-3- (4-HYDROXYPHENYL) -1H-PYRAZOLO [3,4-d] PYRIMIDIN-1-IL) METHYL) -3- (2-CHLOROBENZYL) -4-OXO- 3,4-DIHYDROQUINAZOLINE-5-IL) HEX-5-INOICO; 2-ACETAMIDO-N- (3- (2 - ((4-AMINO-3- (3-HYDROXYPHENYL) -1H-PYRAZOLO [3,4-d] PYRIMIDIN-1-IL) METHYL) -3- (2- CHLOROBENZYL) -4-OXO-3,4-DIHYDROQUINAZOLIN-5-IL) PROP-2-IN-1-IL) ACETAMIDE; AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION. SUCH COMPOUNDS ARE INHIBITORS OF PHOSPHOINOSITIDA 3-KINASES (PI3 KINASES), BEING USEFUL IN THE TREATMENT OF ASTHMA, CYSTIC FIBROSIS, SINUSITIS, ALLERGIC DERMATITIS
priorityDate 2009-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135408753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526621

Total number of triples: 48.